The FDA estimates the PreCheck program could save participating companies up to 14 months by reviewing facilities while they ...
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has ...
3hon MSN
Congress created a drug pricing program to deliver affordability. Instead, it’s raising costs
An autoimmune disease diagnosis can mark the start of a difficult medical battle. But for too many patients, it also marks ...
The agency says pairing drug sponsors with research institutions could cut development timelines by 6 to 12 months ...
Biopharma giants Eli Lilly and Regeneron and rapidly growing contract manufacturers Fujifilm and Cellares are among the seven ...
Strategic collaboration at Sanford, North Carolina facility, currently under construction, to optimize cGMP validation, accelerate time-to-market for complex biologics, and shore up U.S. medicine ...
WASHINGTON — Federal health officials announced a pilot program Monday to speed up early-stage clinical trials, which they ...
Kriya Therapeutics, Inc. ("Kriya"), a biotechnology company developing durable medicines for chronic diseases, today announced it has been selected by the U.S. Food and Drug Administration (FDA) to ...
A new independent analysis of the US Food and Drug Administration's (FDA) workload around biosimilars over the first three years shows how biosimilar development has slowly progressed as companies ...
The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically expedited reviews at the agency, part of an effort to prioritize medicines ...
The Food and Drug Administration Monday announced an initiative to encourage the use of RFID by drug companies. Mark your calendar: June 30, 2026 (10:00 a.m. PDT). A 37.5% ownership interest in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results